Patents by Inventor Harry Ischiropoulos

Harry Ischiropoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the treatment of fatty acid metabolism disorders
    Patent number: 10590063
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: March 17, 2020
    Assignee: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and methods for the treatment of fatty acid metabolism disorders
    Patent number: 10434079
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: October 8, 2019
    Assignee: The Children's Hospital of Philadelphia
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders
    Publication number: 20190062262
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Application
    Filed: November 6, 2018
    Publication date: February 28, 2019
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and methods for the treatment of fatty acid metabolism disorders
    Patent number: 10137103
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: November 27, 2018
    Assignee: The Children's Hospital of Philadelphia
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders
    Publication number: 20180297931
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Application
    Filed: November 7, 2016
    Publication date: October 18, 2018
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders
    Publication number: 20180064674
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Application
    Filed: May 9, 2017
    Publication date: March 8, 2018
    Inventors: Harry Ischiropoulos, Paschalis-Thomas Doulias
  • Compositions and Methods for The Treatment of Fatty Acid Metabolism Disorders
    Publication number: 20160166525
    Abstract: Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.
    Type: Application
    Filed: July 29, 2014
    Publication date: June 16, 2016
    Inventors: Harry ISCHIROPOULOS, Paschalis-Thomas Doulias
  • Materials and methods for the detection of nitrated fibrinogen
    Patent number: 8852879
    Abstract: Compositions are disclosed comprising an effective amount of nitrated fibrinogen and a pharmaceutically acceptable carrier for detecting a patient's risk for coronary artery disease. The compositions can be used to determine the presence of nitrated fibrinogen which is linked with coronary artery disease. Also disclosed is a method for determining the presence or risk for coronary artery disease or risk for increased propensity for an adverse thrombotic event in a patient.
    Type: Grant
    Filed: July 7, 2008
    Date of Patent: October 7, 2014
    Assignee: The Children's Hospital of Philadelphia
    Inventor: Harry Ischiropoulos
  • Materials and Methods for the Detection of Nitrated Fibrinogen
    Publication number: 20090048150
    Abstract: Compositions are disclosed for detecting a patient's risk for coronary artery disease. The compositions can determine the presence of nitrated fibrinogen which is linked with coronary artery disease. Kits for the detection of coronary artery disease are also provided.
    Type: Application
    Filed: July 7, 2008
    Publication date: February 19, 2009
    Inventor: Harry Ischiropoulos
  • Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
    Publication number: 20050244905
    Abstract: Methods and assays are disclosed for predicting a patient's risk for coronary artery disease. The methods comprise obtaining a biological sample from a patient and determining the amount of nitrated fibrinogen which is linked with coronary artery disease. Detection of nitrated fibrinogen is indicative of susceptibility to develop coronary artery disease. Kits for the detection of coronary artery disease are additionally provided. Methods and kits for rapidly forming blood clots are also provided.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 3, 2005
    Inventor: Harry Ischiropoulos